Isocitrate dehydrogenase (IDH) is an important metabolic enzyme in the tricarboxylic acid cycle, whose mutated genes are associated with a variety of tumors, including acute myeloid leukemia (AML), glioma, cholangiocarcinoma, colon cancer and chondrosarcoma (5). This evidence concerns the gene IDH3A and central nervous system cancer.